C14ORF4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62814206561279E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.63757896132211E-12 |
Normal-vs-Stage2 |
1.62592161956354E-12 |
Normal-vs-Stage3 |
1.62492241884138E-12 |
Normal-vs-Stage4 |
1.62714286489063E-12 |
Stage1-vs-Stage2 |
1.339410E-01 |
Stage1-vs-Stage3 |
2.077500E-03 |
Stage1-vs-Stage4 |
2.537000E-01 |
Stage2-vs-Stage3 |
5.313800E-01 |
Stage2-vs-Stage4 |
8.785800E-01 |
Stage3-vs-Stage4 |
4.937800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.33146835171283E-15 |
Normal-vs-AfricanAmerican |
1.79878334449768E-12 |
Normal-vs-Asian |
3.25010018897842E-11 |
Caucasian-vs-AfricanAmerican |
3.260500E-02 |
Caucasian-vs-Asian |
9.197800E-01 |
AfricanAmerican-vs-Asian |
4.076600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62836411021772E-12 |
Normal-vs-Female |
2.33146835171283E-15 |
Male-vs-Female |
5.571600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.80406858527749E-14 |
Normal-vs-Age(41-60Yrs) |
7.7715611723761E-15 |
Normal-vs-Age(61-80Yrs) |
1.62669877568078E-12 |
Normal-vs-Age(81-100Yrs) |
1.11022302462516E-16 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.437200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.410200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.405700E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.364200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.424300E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.029200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.47599743327964E-11 |
Normal-vs-Grade 2 |
2.16493489801906E-14 |
Normal-vs-Grade 3 |
3.33066907387547E-16 |
Normal-vs-Grade 4 |
3.44169137633799E-15 |
Grade 1-vs-Grade 2 |
3.872400E-01 |
Grade 1-vs-Grade 3 |
5.440000E-03 |
Grade 1-vs-Grade 4 |
2.319400E-01 |
Grade 2-vs-Grade 3 |
2.11959999999456E-05 |
Grade 2-vs-Grade 4 |
1.991010E-01 |
Grade 3-vs-Grade 4 |
3.836600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.6251444634463E-12 |
Normal-vs-ccB subtype |
4.32986979603811E-15 |
ccA subtype-vs-ccB subtype |
1.095240E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.66453525910038E-15 |
Normal-vs-N1 |
5.37347943918576E-14 |
N0-vs-N1 |
5.194600E-01 |
|
|